BVS (Bioventus) Quality Rank


BVS Bioventus Inc BVS
60 GF Score
Price $11.88
GF Value $6.81
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Bioventus Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Bioventus Quality Rank Related Terms

BVS
60GF Score
Bioventus Inc BVS
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bioventus (BVS) Overvalued in 2026?

Based on GuruFocus' analysis, Bioventus stock appears to be overvalued. The current stock price of $11.88 is trading 74.4% above its estimated GF Value™ of $6.81. GuruFocus considers Bioventus to be Significantly Overvalued.

Key valuation signals for BVS:

  • Quality Rank:
  • GF Value™: $6.81 vs. price of $11.88 (74.4% above fair value)
  • GF Score™: 60/100 with 7 warning signs

No single metric tells the full story. See the BVS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bioventus Business Description

Other Exchanges 4B8:Germany
Address 4721 Emperor Boulevard, Suite 100, Durham, NC, USA, 27703
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
60GF Score

Get the complete analysis for BVS

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.88
Price
$6.81
GF Value